<h3>Gainers</h3>
<ul>
<li>Radiopharm Theranostics (NASDAQ:RADX) shares increased by 164.1% to $11.25 during Monday's regular session. The company's market cap stands at $33.1 million. </li>
<li>Artiva Biotherapeutics (NASDAQ:ARTV) stock rose 58.63% to $5.24. The company's market cap stands at $80.9 million. </li>
<li>Quipt Home Medical (NASDAQ:QIPT) shares increased by 34.29% to $3.5. The market value of their outstanding shares is at $113.3 million. As per the press release, Q4 earnings came out today. </li>
<li>Climb Bio (NASDAQ:CLYM) shares rose 34.16% to $4.03. The market value of their outstanding shares is at $143.2 million. </li>
<li>Kyverna Therapeutics (NASDAQ:KYTX) stock rose 25.28% to $11.0. The market value of their outstanding shares is at $384.5 million. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 24.62% to $5.92. The market value of their outstanding shares is at $2.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares fell 46.5% to $0.02 during Monday's regular session. </li>
<li>FibroBiologics (NASDAQ:FBLG) shares declined by 33.35% to $0.26. The company's market cap stands at $24.0 million. </li>
<li>Lexaria Bioscience (NASDAQ:LEXX) stock declined by 31.82% to $0.91. The company's market cap stands at $29.7 million. </li>
<li>Processa Pharmaceuticals (NASDAQ:PCSA) stock declined by 29.56% to $0.19. The company's market cap stands at $15.2 million. </li>
<li>AlphaTON Capital (NASDAQ:ATON) stock declined by 28.07% to $0.95. The market value of their outstanding shares is at $10.8 million. </li>
<li>Akanda (NASDAQ:AKAN) shares declined by 27.66% to $0.68. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARTV

RADX

Radiopharm Theranostics shares surged 164.1% to $11.25, while Artiva Biotherapeutics rose 58.63% to $5.24. Quipt Home Medical increased 34.29% to $3.5 following Q4 earnings release. Climb Bio and Kyverna Therapeutics also saw significant gains. Conversely, Bristol-Myers Squibb Celegne shares fell 46.5% to $0.02, with FibroBiologics, Lexaria Bioscience, and others experiencing declines. The article was generated by Benzinga's automated content engine.

12 Health Care Stocks Moving In Monday's Intraday Session